News

Under the terms of the agreement, Forest will initially pay Microbia $70 million in licensing fees. Microbia and Forest will jointly and equally fund development and commercialization of

Glucagon is a hormone produced by the pancreas that stimulates the liver to produce glucose (sugar). Overproduction of glucose by the liver is an important cause of high

Gwen Krivi, vice president of Lilly research laboratories, said: “The FDA’s decision marks a major milestone. For the first time, postmenopausal women with osteoporosis will have one treatment

Bayer will manufacture Betaseron at the Emeryville site, retain full control of all manufacturing and process technology used in the production of Betaseron (interferon beta-1b) and has retained

GSK had requested to initiate its review of XL880 before the compound reaches proof-of-concept as defined under the product development and commercialization agreement between the two companies. GSK

Ms Lacerca has experience in multi-jurisdictional corporate compliance, international business transactions, pharmaceutical industry regulation, corporate policy and international environmental law. She joins Mylan from Bristol-Meyers Squibb where she

Encysive received European marketing authorization for Thelin in August 2006. Thelin is the first selective endoThelin A receptor antagonist, and the first once-daily oral treatment available for patients

According to the company, this is the first approval for Dr Reddy's US over-the-counter (OTC) business to launch a Store Brand OTC Division in the US. Ranitidine is

Mr Junien has experience both in Europe and in the US in managing preclinical and clinical developments. Mr Motesharei is a former biotech executive with over 10 years